Treatment of Von Willebrand's Disease
- 1 October 1992
- journal article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 6 (5) , 1079-1094
- https://doi.org/10.1016/s0889-8588(18)30295-8
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patientsBlood, 1991
- Platelet aggregation and pseudothrombocytopenia induced by 1‐desamino‐8‐D‐arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patientEuropean Journal of Haematology, 1990
- DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factorBlood, 1989
- Biochemical and in vivo properties of commercial virus‐inactivated factor VIII concentratesEuropean Journal of Haematology, 1988
- Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.Journal of Clinical Investigation, 1986
- Estrogens and surgery in women with von Willebrand's diseaseThe American Journal of Medicine, 1982
- High potency factor VIII concentrate: More effective than cryoprecipitate in a patient with Von Willebrand's disease and inhibitorThrombosis Research, 1979
- A Hemorrhagic Syndrome in Waldenström's Macroglobulinemia Secondary to Immunoadsorption of Factor VIIINew England Journal of Medicine, 1979
- Antihemophilic Factor Concentrate Therapy in von Willebrand DiseasePublished by American Medical Association (AMA) ,1976
- Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's diseaseNature, 1975